
Click to enlarge image
US/Washington: Medique, a Fort Myers, Florida establishment, recalls an estimated 143,300 Medi-First, Medi-First Plus, Medique, Dover, Otis Clapp and Ecolab branded medications and/or health products from the American marketplace due to suspected failure to meet US child resistant closure requirements under the US Poison Prevention Packaging Act and consequential risks of child poisoning, ingestion and GI tract laceration damage, all serious health and safety hazards.
CPSC: http://ht.ly/aPaY30r9OOg
Direct link: https://www.cpsc.gov/Recalls/2020/Medique-Recalls-31-Different-Over-the-Counter-Drugs-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning-Sold-Exclusively-on-Amazon-com-Recall-Alert
Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports the recall involves 31 different over-the-counter drugs purchased on or after June 1, 2018 that are unexpired from the following brands: Medi-First, Medi-First Plus, Medique, Dover, Otis Clapp and Ecolab, as follows (in alphabetical order):
Continue reading →
Like this:
Like Loading...
Filed under: Children, Dietary Supplements, Drugs, Home & Residential, Ingestion hazard, Labeling or regulatory issues, US CPSC | Tagged: Acetaminophen, Aspirin, children, CPSC, CPSC recall number: 20-780, Dietary Supplements, Diphenhydramine, Drugs, Ibuprofen, Infant, infants, Lidocaine, Loperamide, medications, Naproxen, pain, pain relievers, poisoning hazards, Recalls Direct RIN: 13510-2020, suspected failure to meet US Child Resistant Closure Requirement, US Consumer Product Safety Commission, US Poison Prevention Packaging Act | Leave a comment »